GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Marketable Securities

Abbisko Cayman (STU:8ZD) Marketable Securities : €0.12 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Abbisko Cayman's Marketable Securities for the quarter that ended in Dec. 2023 was €0.12 Mil.

Abbisko Cayman's annual Marketable Securities increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€12.70 Mil) but then declined from Dec. 2022 (€12.70 Mil) to Dec. 2023 (€0.12 Mil).


Abbisko Cayman Marketable Securities Historical Data

The historical data trend for Abbisko Cayman's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Marketable Securities Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
- - - 12.70 0.12

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Marketable Securities Get a 7-Day Free Trial - - 12.70 12.65 0.12

Abbisko Cayman Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Abbisko Cayman  (STU:8ZD) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Abbisko Cayman Marketable Securities Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman (STU:8ZD) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines